BCN Peptides is working in a research program having as therapeutic target Lysosomal Storage diseases, a group or rare inherited metabolic disorders that result from defects in lysosomal function.

The project, enclosed in “Nuclis d’Innovació Tecnològica” program from ACCIÓ, is cofinanced with the European Union FEDER funds.